{
    "2020-06-01": [
        [
            {
                "time": "2020-06-01",
                "original_text": "A股共发生139宗大宗交易成交24.53亿元（6月1日）",
                "features": {
                    "keywords": [
                        "大宗交易",
                        "A股",
                        "成交额"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "全市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-01",
                "original_text": "华兰生物现1笔大宗交易 共成交207.50万元",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "大宗交易",
                        "成交额"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-06-01",
                "original_text": "【国信医药】积极关注集采外领域，海外疫情拉动IVD板块（周观点）",
                "features": {
                    "keywords": [
                        "国信医药",
                        "集采",
                        "海外疫情",
                        "IVD板块"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "IVD"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-01",
                "original_text": "华兰生物今日大宗交易成交5万股，成交价41.5元溢价0.0%",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "大宗交易",
                        "溢价"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-06-01",
                "original_text": "揭秘送转股 105只除权以来股价上涨",
                "features": {
                    "keywords": [
                        "送转股",
                        "股价上涨"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "全市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-01",
                "original_text": "高估值引发医药板块投资分歧 主题投资宜关注生物疫苗指基",
                "features": {
                    "keywords": [
                        "高估值",
                        "医药板块",
                        "投资分歧",
                        "生物疫苗"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-06-01",
                "original_text": "A股早报2020年6月1日星期一",
                "features": {
                    "keywords": [
                        "A股早报"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "全市场"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-06-01",
                "original_text": "六月金股一览",
                "features": {
                    "keywords": [
                        "六月金股"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "全市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-01",
                "original_text": "中泰证券：后疫情时期重点关注医疗器械、疫苗和CXO板块投资机会",
                "features": {
                    "keywords": [
                        "中泰证券",
                        "后疫情",
                        "医疗器械",
                        "疫苗",
                        "CXO板块"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "医疗器械",
                        "疫苗",
                        "CXO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}